- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04120220
Shake It Up: Lipidomics of Lipoproteins and Diet
August 1, 2022 updated by: USDA Grand Forks Human Nutrition Research Center
The purpose of this research is to understand how dietary fat is related to cardiovascular disease (CVD).
This study tests the effect of different dietary fats on the level of fat in the blood and the particles that transport fat in the blood.
The researchers want to know if these particles change after eating meals made with different fats.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The overall objective of this work is to discover how the lipidomic composition of postprandial lipoproteins responds to dietary fats of differing fatty acid composition by comparing meals rich in saturated fatty acid (SFA) (from dairy cream) versus polyunsaturated fatty acids (PUFA) (from soybean oil).
The information derived from these studies will provide mechanistic insight into postprandial lipid metabolism and will support efforts to identify optimal dietary oil intakes for people.
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Dakota
-
Grand Forks, North Dakota, United States, 58203
- USDA Grand Forks Human Nutrition Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Normal to overweight (BMI 18.0-29.9 kg/m^2
- Willing to comply with the demands of the experimental protocol
Exclusion Criteria:
- Inability to provide consent
- Have fasting blood glucose <60 mg/dL or >126 mg/dL
- Have fasting blood cholesterol >300 mg/dL
- Have fasting blood triglyceride <100 mg/dL or >300 mg/dL
- Have uncontrolled hypertension (blood pressure >140/90 mm Hg)
- Take prescription medications for blood sugar or lipid management or anti-inflammatory steroids (e.g. cortisone)
- Over the counter use of supplements (fish oil, flax, plant sterol or sterol esters) and unwilling to discontinue use for 6 weeks prior to study initiation
- Have a history of an eating disorder, unusual dietary pattern (extreme nutrient or food group restriction; erratic meals due to shift work, etc.)
- Have established cardiovascular, pulmonary, and/or a metabolic disease such as diabetes
- Have cancer
- Use tobacco products or nicotine in any form including snuff, pills, and patches, or e-cigarettes/vaping in the past 6 weeks
- Have alcohol, anabolic steroids, or other substance abuse issues
- Consume more than 3 alcoholic drinks/week
- Are lactose intolerant or have an allergy to dairy foods
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Heavy Cream
Participants will receive a meal containing 30 g of fat prepared with heavy cream.
|
Participants will receive a meal in the form of a fruit-containing shake containing 30 g of fat prepared with heavy cream.
|
Experimental: Soybean Oil
Participants will receive a meal containing 30 g of fat prepared with soybean oil.
|
Participants will receive a meal in the form of a fruit-containing shake containing 30 g of fat prepared with soybean oil.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in lipidomic composition of plasma post-prandial lipoproteins as assessed by incremental area under the curve (iAUC)
Time Frame: 0, 1, 2, 4, 6, 8 hours post meal intake
|
0, 1, 2, 4, 6, 8 hours post meal intake
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Matthew Picklo, PhD, USDA Grand Forks Human Nutrition Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 12, 2019
Primary Completion (Actual)
May 20, 2022
Study Completion (Actual)
May 20, 2022
Study Registration Dates
First Submitted
October 7, 2019
First Submitted That Met QC Criteria
October 7, 2019
First Posted (Actual)
October 9, 2019
Study Record Updates
Last Update Posted (Actual)
August 4, 2022
Last Update Submitted That Met QC Criteria
August 1, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GFHNRC511
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Children's Hospital Los AngelesUniversity of Southern California; Tufts Medical CenterRecruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Khyber Medical University PeshawarRecruitingObesity, OverweightPakistan
-
National Taiwan University HospitalCompleted
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.RecruitingBody Weight | Overweight and ObesityCroatia
Clinical Trials on Heavy Cream
-
University of WashingtonNational Institute on Aging (NIA)RecruitingDementia | Alzheimer DiseaseUnited States
-
Balikesir UniversityCompleted
-
Norwegian School of Sport SciencesUniversity of Oslo; Oslo University Hospital; University of Copenhagen; University... and other collaboratorsCompleted
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
University Hospital, GhentCompletedAchilles TendinopathyBelgium
-
University of Southern DenmarkRegion of Southern Denmark; The Danish Rheumatism Association; Esbjerg MunicipalityCompletedHypermobility Syndrome Shoulder | Shoulder Pain ChronicDenmark
-
Henan University of Traditional Chinese MedicineRecruitingAllergic RhinitisChina
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
CNAO National Center of Oncological HadrontherapyRecruitingCancer | Radiation Toxicity | Oncology | Radiotherapy Side Effect | Radiation Exposure | Rare DiseaseItaly